A significant shift in our drug policy has occurred, as the regulators permit the use of psilocybin hallucinogens for therapeutic treatment. Previously, these substances were severely restricted, but a mounting body of research suggests they potentially offer benefits for emotional conditions like PTSD. This development represents a major step towa